back to top
My wish lists
Save your wish list
If you want to add more content to your wish list, simply log in. If you do not have a user account, please register for the Hanser Customer Center.

» Do you already have a user account? Please log in here.
» Don't have a user account yet? Please register here.
Your wish lists
If you want to use your wish list during your next visit, simply log in. If you do not have a user account, please register for the Hanser Customer Center.
» Do you already have a user account? Please log in here.
» Don't have a user account yet? Please register here.

« Back

Your advantages at a glance

  • One login for all Hanser portals
  • Individual home page for faster access to preferred content
  • Exclusive access to selected content
  • Personal wish lists on all portals
  • Central management of your personal information and newsletter subscriptions

Register now
Deutsch
Bookmark Bookmarked
10-17-2020

Increased Dose Reliability

Static Reducing Compounds for Drug Delivery Devices

Clariant Plastics & Coatings Healthcare Polymer Solutions, Muttenz, Switzerland, launched static-reducing functional plastic compounds which, when used in drug delivery devices, enable increased dose reliability. The resins are part of the wider medical grade Mevopur line of color and additive concentrates and ready-to-use polymer compounds, covering polymers from PE to PEEK.

Plastics are insulators, and therefore prone to build-up of static charges. In applications where plastics are in contact with powders, the powder can stick to the surface. In drug delivery devices, such as dry powder inhalers, this sticking effect reduces the dose reliability and repeatability. Mevopur permanent antistatic compounds reduce the surface resistivity and dissipate charges quickly, thereby eliminating sticking. However, since the plastics often have direct drug contact, and inhalation is considered as a medium-to-high risk drug administration route, the plastic materials need to be evaluated for biocompatibility and risk of potential leachables.

Development Program

In a recent development program with a leading European pharmaceutical company, members of Clariant’s global Healthcare Polymer Solutions team provided technical support and compounded materials covering ABS, COP (cyclic olefin polymer) and PP resins that the development team planned to use. The critical areas in contact with the drug flow needed to avoid static charge build-up, and the Mevopur antistatic agent, combined with the chosen polymer, demonstrated antistatic functionality that significantly reduced this problem. In other development programs, antistatic functionality was combined with the chosen color in one compound product.

Although many resins are now widely available as ‘medical grade’ products with supporting regulatory declarations and change notification, this usually only covers the resin, and not colors or additives that are introduced by compounding or masterbatch concentrates. It is these colors and additives that present the higher risk of potential leachables that could end up in the drug. The problem is particularly acute as these added materials change routinely over the life time of the product.

Pre-Tested Ingredients

The Mevopur family significantly reduces this risk by using pre-tested ingredients that support compliance to medical and pharmaceutical standards such as ISO10993 and USP Class VI, manufactured in EN- ISO13485:2016 certified production facilities and change control.

Other examples where the anti-static compounds are applied in drug delivery is in transparent plastic ‘spacer’ accessories used with metered-dose inhalers (MDI). These spacers which act as ‘accumulators’ to aid in correct dosing, are mainly used by very young or elderly patients who have difficulty to use an MDI unaided. Although anti-static functionality is needed, the materials used are often not ‘medical grade’, and so they can present the same risk as the described above. Mevopur antistatic compounds are available both in opaque colors and in transparent MABS (methyl methacrylate-acrylonitrile-butadiene-styrene) delivering the same quality and regulatory compliance.

Additional information
  • Published in Kunststoffe international 2019/09

    Recycling Is the Basis

    Clariant at K 2019

    With its new additives, Clariant International aims to increase recycling rates for post-consumer waste.   more

    Clariant International Ltd.

  • About Drivers and the Driven
    Kunststoffe international 2019/08, PAGE 12 - 16

    About Drivers and the Driven

    Raw Materials Producers See Signs of the Times, and Implement them in Different Ways

    Whether it was the motto presented by the trade fair’s committee or threatened prohibition proceedings: material producers are getting more...   more

  • 11-07-2018

    Replacing Fossil-Based Ethylene and Propylene

    Neste and Clariant Develop Sustainable Industrial Solutions

    Neste and Clariant have signed an agreement for a new partnership to join forces in developing and making new sustainable material solutions accessible to a variety of industries.   more

Company profile

Clariant International Ltd.

Rothausstraße 61
CH 4132 MUTTENZ 1
Tel.: +41 61 4697747
Fax: +41 61 4697587

These articles might be interesting for you
Patents Stimulate Innovation

Patents encourage innovation: Stay on the ball with the latest innovations in the plastics industry in our patents section.

Patents

Newsletter

Would you like to subscribe to our Newsletters on plastics technology and profit from the latest information?

Subscribe here

Subscribe here

Trade Names

You know the trade name but want to know the material manufacturer, type of polymer and delivery form? Search here!

Trade Names